← All companies
CRISPR Therapeutics AG
CRSP - CIK 0001674416
Market cap$4.80 B
Rank#1436
SEC filings837
Market capitalization of CRISPR Therapeutics AG
As of 2026-06-13, CRISPR Therapeutics AG (CRSP) has a market capitalization of $4.80 B, making it the #1436 most valuable US-listed company.
Recent market cap readings
| Date | Market cap |
|---|---|
| 2026-06-13 | $4.80 B |
| 2026-06-12 | $4.91 B |
| 2026-06-11 | $4.82 B |
| 2026-06-10 | $4.77 B |
| 2026-05-29 | $5.40 B |
| 2026-05-28 | $5.16 B |
| 2026-05-26 | $4.92 B |
| 2026-05-25 | $4.86 B |
| 2026-05-24 | $4.86 B |
| 2026-05-22 | $4.86 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
Market Cap of similar companies
Frequently asked questions
What is CRISPR Therapeutics AG's market cap?
As of 2026-06-13, CRISPR Therapeutics AG (CRSP) has a market capitalization of $4.80 B, making it the #1436 most valuable US-listed company.
Where does CRISPR Therapeutics AG rank by market cap?
CRISPR Therapeutics AG is the #1436 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.